Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The inactivation approach presented in this technology provides for a safe, non-infectious composition for vaccination against the corresponding agent. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 40 pages - $500
May 2008 - 70 pages - $1,999
Oct 2009 - 17 pages - $500
Oct 2011 - 150 pages - $3,500
Sep 2011 - 110 pages - $1,000
Oct 2009 - 30 pages - $995
Mar 2011 - 32 pages - $250
Nov 2011 - 7 pages - $3,835
Jun 2006 - 1458 pages - $2,495
Your selection
Browse By
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us